Cite
HARVARD Citation
Schoen, L. et al. (2022). The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitro. Journal of cellular and molecular medicine. 26 (23), pp. 5832-5845. [Online].